Averica Discovery Services has announced the expansion of its Pharmaceutical Impurities services.
The new services include nitrosamines impurities, extractables and leachables, and PFAS testing.
"Our unique approach to impurity isolation; allows us to use our scalable separation expertise to isolate significant amounts of unknown chemical impurities," the company states.
The US-based company also provides a wide range of other pharmaceutical services.